Literature DB >> 6895078

Cyclic combination chemotherapy of canine lymphosarcoma.

E G MacEwen, N O Brown, A K Patnaik, A A Hayes, S Passe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6895078

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN： 0003-1488            Impact factor:   1.936


× No keyword cloud information.
  5 in total

1.  A review of cancer chemotherapy for pet animals.

Authors:  A M Norris; S J Withrow
Journal:  Can Vet J       Date:  1984-04       Impact factor: 1.008

2.  Canine lymphoma-associated antigens defined by murine monoclonal antibodies.

Authors:  Z Steplewski; K A Jeglum; C Rosales; N Weintraub
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma.

Authors:  H B Muss; N Spell; D Scudiery; R L Capizzi; M R Cooper; J Cruz; D V Jackson; F Richards; C L Spurr; D R White
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

4.  Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.

Authors:  Cecile T Siedlecki; Philip H Kass; Martin J Jakubiak; Gillian Dank; Jarred Lyons; Michael S Kent
Journal:  Can Vet J       Date:  2006-01       Impact factor: 1.008

5.  The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation.

Authors:  R F Carter; V E Valli; J H Lumsden
Journal:  Can J Vet Res       Date:  1986-04       Impact factor: 1.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.